Skin Reactions in a Subset of Patients With Stage IV Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen 4 Monoclonal Antibody as a Single Agent | Zendy

Samer H. Jaber | Zendy; Edward W. Cowen | Zendy; Leah Haworth | Zendy; Susan Booher | Zendy; David M. Berman | Zendy; Steven A. Rosenberg | Zendy; Samuel Hwang | Zendy

Open Access

Skin Reactions in a Subset of Patients With Stage IV Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen 4 Monoclonal Antibody as a Single Agent

Author(s) -

Samer H. Jaber,

Edward W. Cowen,

Leah Haworth,

Susan Booher,

David M. Berman,

Steven A. Rosenberg,

Samuel Hwang

Publication year - 2006

Publication title -

archives of dermatology

Language(s) - English

Resource type - Journals

eISSN - 1538-3652

pISSN - 0003-987X

DOI - 10.1001/archderm.142.2.166

Subject(s) - medicine , pathology , antigen , monoclonal antibody , eosinophil , cytotoxic t cell , dermis , antibody , immunology , in vitro , biochemistry , chemistry , asthma

To describe the clinical and histologic manifestations of skin reactions incidentally noted in patients with stage IV melanoma who were treated with up to 9 mg/kg of a humanized monoclonal antibody reactive against human cytotoxic T-lymphocyte antigen 4 (anti-CTLA-4) as a single agent every 3 weeks.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research